Does SIMVASTATIN Cause Type iia hyperlipidaemia? 63 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Type iia hyperlipidaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.2% of all adverse event reports for SIMVASTATIN.
63
Reports of Type iia hyperlipidaemia with SIMVASTATIN
0.2%
of all SIMVASTATIN reports
55
Deaths
13
Hospitalizations
How Dangerous Is Type iia hyperlipidaemia From SIMVASTATIN?
Of the 63 reports, 55 (87.3%) resulted in death, 13 (20.6%) required hospitalization.
Is Type iia hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Type iia hyperlipidaemia?
ATORVASTATIN (67)
EZETIMIBE (67)
EVOLOCUMAB (66)
ROSUVASTATIN (63)
LOMITAPIDE (59)
LOVASTATIN (56)
PROBUCOL (56)
IMPLITAPIDE (49)
CAFFEINE\PROCAINE (10)
TOCILIZUMAB (8)
Which SIMVASTATIN Alternatives Have Lower Type iia hyperlipidaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS